Tiago Girão

Tiago Girão

Director/Board Member chez LANDOS BIOPHARMA, INC.

Fortune : 2 $ au 31/03/2024

44 ans
Health Technology
Commercial Services
Consumer Services

Profil

Tiago M.
Girão
is an Independent Director at Landos Biopharma, Inc. and the Chief Financial Officer at Proteovant Therapeutics, Inc. He previously worked as the International Controller at NuVasive, Inc. from 2012 to 2014, as a Senior Manager at KPMG LLP from 2000 to 2004, as the Chief Financial Officer & Vice President at Plus Therapeutics, Inc. from 2014 to 2015, as a Senior Accountant at Ernst & Young Terco, and as the Chief Financial Officer at Roivant Sciences, Inc. He also served as the Chief Financial Officer & Senior VP-Operations at Cytori Therapeutics, Inc. from 2014 to 2019.
Girão received his undergraduate degree from the University of Fortaleza.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
25/07/2018 1 ( 0,11% ) 2 $ 31/03/2024
23/05/2023 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Tiago Girão

SociétésPosteDébut
LANDOS BIOPHARMA, INC. Director/Board Member 08/04/2021
Proteovant Therapeutics, Inc. Director of Finance/CFO -
Tous les postes actifs de Tiago Girão

Anciens postes connus de Tiago Girão

SociétésPosteFin
PLUS THERAPEUTICS, INC. Director of Finance/CFO 31/03/2019
Director of Finance/CFO 01/03/2019
NUVASIVE, INC. Comptroller/Controller/Auditor 01/08/2014
Corporate Officer/Principal 01/08/2004
Director of Finance/CFO -
Voir l'expérience en détail de Tiago Girão

Formation de Tiago Girão

University of Fortaleza Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Tiago Girão

Relations

100 +

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
PLUS THERAPEUTICS, INC.

Health Technology

LANDOS BIOPHARMA, INC.

Health Technology

Entreprise privées6

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Proteovant Therapeutics, Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Tiago Girão